Artigo
Revisado por pares
Hydrolysis of thalidomide abrogates its ability to enhance mononuclear cell synthesis of IL-2 as well as its ability to suppress the synthesis of TNF-α
1997; Elsevier BV; Volume: 36; Issue: 1 Linguagem: Inglês
10.1016/s0162-3109(96)00154-3
ISSN1879-047X
AutoresEmer Shannon, Felipe Sandoval, James L. Krahenbuhl,
Tópico(s)PARP inhibition in cancer therapy
Referência(s)